(Press-News.org) Immunologist Chrysothemis Brown, MD, PhD, whose research has been shedding light on the development of the early life immune system and its relationship to autoimmunity, allergy, inflammation, and cancer, was among 30 early-career scientists nationwide selected for the 2025 class of Howard Hughes Medical Institute (HHMI) Freeman Hrabowski Scholars.
The prestigious honor supports outstanding basic researchers, including physician-scientists who have strong potential to become leaders in their fields and who have fostered a lab environment in which everyone can thrive.
“I’m honored and grateful to be named a Freeman Hrabowski Scholar,” says Dr. Brown, an assistant attending physician at Memorial Sloan Kettering Cancer Center (MSK) and an assistant member of MSK’s Immuno-Oncology Program. “This support will enable our lab to pursue bold, curiosity-driven research on early life immune development and tolerance, while building an inclusive, collaborative environment to train the next generation of scientists.”
Freeman Hrabowski Scholars are appointed to a five-year term, which is renewable, and receive support that includes a full salary, benefits, a research budget, and scientific equipment. The program also helps develop scholars’ leadership and mentoring skills.
“We are incredibly proud of Dr. Brown’s inclusion in the 2025 class of scholars,” says Joan Massagué, PhD, who recently served as MSK’s Chief Scientific Officer. “This recognition is a testament to Dr. Brown’s groundbreaking work in understanding the intricate balance of immune tolerance and her dedication to developing a positive research environment. This recognition not only highlights her potential to transform the landscape of immunology and immuno-oncology but also underscores the importance of supporting and developing the upcoming generation of scientific leaders.”
Dr. Massagué also notes that the new class of scholars includes two MSK alumna: Corina Amor Vega, MD, PhD, of Cold Spring Harbor Laboratory, a former postdoctoral researcher in the lab of Scott Lowe, PhD; and Elizabeth Wasmuth, PhD, of the University of Texas Health Science Center at San Antonio, a former postdoc in the lab of Charles Sawyers, MD.
Dr. Brown did her undergraduate medical training at Oxford University and University College London. She trained in pediatrics in London and obtained her doctorate in immunology. She then joined the lab of Alexander Rudensky, PhD, Chair of the Immunology Program at MSK’s Sloan Kettering Institute, to pursue studies in the transcriptional and epigenetic regulation of immune cell fate. There she discovered new immune cell subsets and their transcriptional regulators. She also pioneered single-cell transcriptomic studies of pediatric autoimmune disease and human cancer, uncovering a new type of antigen-presenting cell that promotes tolerance to helpful bacteria in the gut in early life.
Earlier this year, her lab published a study in Science showing how these immune cells play an essential and previously unknown role in suppressing inflammatory responses to food.
“Our research aims to answer longstanding questions in immune tolerance by integrating new insights gained from discoveries of specialized antigen-presenting cells with a rich body of foundational research,” she says. “Our goal is to uncover fundamental mechanisms that could ultimately shape our understanding and treatment of immune-related diseases.”
Dr. Brown has also received several other notable awards including the National Institute of Allergy and Infectious Diseases New Innovator Award, a Pew Biomedical Scholar Award, a Josie Robertson Young Investigator Award, and a Pershing Square Sohn Cancer Prize.
END
Immunologist Chrysothemis Brown named a 2025 Howard Hughes Medical Institute Freeman Hrabowski Scholar
2025-10-01
ELSE PRESS RELEASES FROM THIS DATE:
Science newswire EurekAlert! quadruples academic papers’ media coverage potential
2025-10-01
Broad public understanding of scientific discoveries has traditionally been shaped by mainstream media coverage. To better understand the process of communicating academic publications to popular media, a team from Harvard University analyzed 1,155 archaeology papers published in one specialist and six general science journals over six years and the resulting media coverage.
The team found that archaeology journal articles with news releases on EurekAlert!, a news release distribution platform operated by the non-profit American Association for the Advancement of Science (AAAS), were about four times more likely to receive ...
Study reveals genetic and developmental differences in people with earlier versus later autism diagnosis
2025-10-01
Researchers find different genetic profiles related to two trajectories that autistic children tend to follow. One linked to early diagnosis, and communication difficulties in infancy. The other linked to later diagnosis, increased social and behavioural difficulties in adolescence, and higher rates of conditions like ADHD, depression, and PTSD.
An international study led by researchers at the University of Cambridge has discovered that autism diagnosed in early childhood has a different genetic and developmental profile to autism diagnosed from late childhood onwards.
The scientists say that ...
MIT study suggests a cysteine-rich diet may promote regeneration of the intestinal lining
2025-10-01
CAMBRIDGE, MA -- A diet rich in the amino acid cysteine may have rejuvenating effects in the small intestine, according to a new study from MIT. This amino acid, the researchers discovered, can turn on an immune signaling pathway that helps stem cells to regrow new intestinal tissue.
This enhanced regeneration may help to heal injuries from radiation, which often occur in patients undergoing radiation therapy for cancer. The research was conducted in mice, but if future research shows similar results in humans, then delivering elevated quantities of cysteine, ...
Taming the “bad” oxygen
2025-10-01
Researchers from the Freunberger group at the Institute of Science and Technology Austria (ISTA) have unveiled pivotal insights into the redox chemistry of oxygen and reactive oxygen species (ROS). While some ROS play essential roles in cell signaling, the particularly harmful singlet oxygen damages cells and degrades batteries. For the first time, the team uncovers a way to tune it. The results, published in Nature, could have broad applications, including in energy storage processes.
While “oxidation” sounds oddly similar to “oxygen,” the two words have little in common. Oxidation-reduction—or ...
CATNIP for chemists: New data-driven tool broadens access to greener chemistry
2025-10-01
University of Michigan and Carnegie Mellon University researchers have developed a new tool that makes greener chemistry more accessible.
The tool, described in a study supported by the U.S. National Science Foundation and scheduled to publish Oct. 1 in the journal Nature, removes a major barrier to wider adoption of biocatalysis.
Biocatalysts, also called enzymes, are a type of protein that have evolved to perform chemistry that can be complex and incredibly efficient—typically in water and at room temperature—removing the need for toxic or expensive chemical reagents to run reactions. But they are also ...
New research shows global economy doubles, but poverty persists and planetary damage deepens
2025-10-01
A new study published in Nature shows that as the global economy more than doubled between 2000 and 2022, it still left billions of people without life’s essentials, while rapidly pushing Earth’s life-supporting systems further beyond safe limits.
For the first time, researchers have created an annual global dashboard that tracks 21st century trends in social shortfall and ecological overshoot, and reveals the extent to which wealthy countries drive most of the overshoot while poorer countries bear the brunt of deprivation.
The co-authors of the study, ...
For people without diabetes, continuous glucose monitors may not accurately reflect blood sugar control
2025-10-01
Continuous glucose monitors (CGMs) are wearable technologies that track blood sugar in real time and help patients with type 2 diabetes improve blood sugar control. In 2024, the U.S. Food and Drug Administration approved over-the-counter CGMs for individuals with and without diabetes, but there is limited understanding of how to interpret CGM metrics in individuals who do not have diabetes. Researchers from Mass General Brigham analyzed CGM data from people with diabetes, prediabetes, and normal glycemic control, finding that while CGM metrics in patients with diabetes correlated with hemoglobin ...
New study shows wearable patch reduces alcohol and drug cravings, and substance use
2025-10-01
A new study by investigators from Mass General Brigham shows that a non-drug, wearable device can help people with substance use disorders (SUD) manage stress, reduce cravings, and lower their risk of relapse in real time. Their results are published in JAMA Psychiatry.
"One of the hallmarks of early addiction recovery is poor self-awareness of emotional states," said corresponding author David Eddie, PhD, a Mass General Brigham psychologist at the Recovery Research Institute at Massachusetts General Hospital. "People in recovery can experience a lot of stress, but they often don’t have great awareness of it or proactively ...
Clinical characteristics of adults at risk of Medicaid disenrollment due to HR 1 work requirements
2025-10-01
About The Study: Approximately 5 million adults are at risk of Medicaid disenrollment due to HR 1’s work requirements. This population, particularly those ages 50 to 64, has high prevalences of chronic and potentially function-limiting conditions.
Corresponding Author: To contact the corresponding author, Ashwin K. Chetty, BS, email ashwin.chetty@yale.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2025.16533)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and ...
New discovery of Jurassic reptile blurs the line between snake and lizard
2025-10-01
New research has uncovered a species of hook-toothed lizard that lived about 167 million years ago and has a confusing set of features seen in snakes and geckos—two very distant relatives. One of the oldest relatively complete fossil lizards yet discovered, the Jurassic specimen is described in a study, published today in the journal Nature, from a multinational collaboration between the American Museum of Natural History and scientists in the United Kingdom, including University College London and the National Museums Scotland, France, and South Africa.
The ...